Sanara Medtech (NASDAQ: SMTI) net income
Sanara Medtech reported a net loss of $37.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $9.7m. Earnings per share were −$4.36.
Sanara Medtech's best year of the last 10 was fiscal 2017. It reported a loss in 9 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$37.6m | — | −36.4% | −$4.36 |
| 2024 | −$9.7m | — | −11.2% | −$1.14 |
| 2023 | −$4.3m | — | −6.6% | −$0.52 |
| 2022 | −$7.9m | — | −17.3% | −$1.00 |
| 2021 | −$7.9m | — | −32.8% | −$1.08 |
| 2020 | −$4.4m | — | −28.5% | −$0.76 |
| 2019 | −$2.8m | — | −23.9% | −$1.32 |
| 2018 | −$0.6m | −281.3% | −10.3% | $0.00 |
| 2017 | $0.3m | — | 5.3% | $0.00 |
| 2016 | −$0.4m | — | −7.5% | −$0.01 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Sanara Medtech net income compared with its sector
By net income for its latest fiscal year, Sanara Medtech ranks 233rd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Sanara Medtech, −36.4%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 231st | Context Therapeutics | −$36.1m | — |
| 232nd | AngioDynamics | −$36.7m | −11.5% |
| 233rd | Sanara Medtech | −$37.6m | −36.4% |
| 234th | Candel Therapeutics | −$38.2m | — |
| 235th | Sight Sciences | −$38.4m | −49.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Sanara Medtech
- How much did Sanara Medtech earn in fiscal 2025?
- Sanara Medtech reported a net loss of $37.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $9.7m.
- What are the earnings per share of Sanara Medtech?
- They were −$4.36 in fiscal 2025, compared with −$1.14 in fiscal 2024.
- What was the most profitable year for Sanara Medtech?
- Of its last 10 fiscal years, fiscal 2017, with $0.3m.
- Where does Sanara Medtech rank in its sector by net income?
- It ranks 233rd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Sanara Medtech come from?
- From the annual report (Form 10-K) that Sanara Medtech files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Sanara Medtech files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Sanara Medtech: the Sanara Medtech page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.